Loading
Latest filing published 21 Jan 2009 for REGEN BIOLOGICS INC, €47k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
J. Richard Steadman appears in our data through filings on Regen Biologics Inc shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 1 June 2006 to 16 January 2009.
Every open-market trade on record is a purchase: 2 purchases worth €83k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 option exercise. 2009 to date brings 1 purchase and no sales.
The latest filing, published on 21 January 2009, reports a transaction of €47k in Regen Biologics Inc. The clock since the last published purchase (21 January 2009) now reads 6,485 days. The median gap between a trade and its publication by SEC (Form 4) is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations